ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AMLX Amylyx Pharmaceuticals Inc

2.88
0.00 (0.00%)
Last Updated: 06:53:10
Delayed by 15 minutes

Amylyx Pharmaceuticals Financial Summary

The current AMLX market cap is 195.21M. The company's latest EPS is USD 0.7269 and P/E is 3.96.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 345k21.89M71.43M98.22M102.69M
Operating Income -54.68M-44.59M-2.05M20.2M18.72M
Net Income -53.76M-42.7M1.57M22.07M20.89M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.43M1.43M285k22.23M380.79M
Operating Income -13.55M-13.55M-82.69M-201.34M38.8M
Net Income -13.72M-13.72M-87.93M-198.38M49.27M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 181.44M391.45M407.96M453.59M466.58M
Total Liabilities 37.42M50.85M55.31M67.22M48.18M
Total Equity 144.03M340.61M352.65M386.37M418.4M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 3.22M14.1M105.61M391.45M517.45M
Total Liabilities 20.9M8.77M17.43M50.85M84.02M
Total Equity -25.36M-66.73M-151.17M340.61M433.43M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -130.17M-179.87M-5.07M3.54M-1.63M
Investing -10.81M-238.99M55.99M179.22M71.13M
Financing 199.63M431.79M1.04M2.42M3.31M
Year End 31 December 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -10.69M-10.69M-74.8M-179.87M11.92M
Investing N/A N/A -46.41M-238.99M92.05M
Financing 668k668k158.51M431.79M3.54M
Market Cap 195.21M
Price to Earnings Ratio 3.96
Price to Sales Ratio 0.51
Price to Cash Ratio 1.15
Price to Book Ratio 0.45
Dividend Yield -

Share Statistics

Shares Outstanding 67.78M
Average Volume (1 week) 2.19M
Average Volume (1 Month) 6.51M
52 Week Change -90.54%
52 Week High 31.77
52 Week Low 2.67
Spread (Intraday) 0.01 (0.35%)

Company Info

Company Name Amylyx Pharmaceuticals Inc
Address 251 little falls drive
wilmington, delaware 19808
Website https://www.amylyx.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock